nach oben

Erschienen in:

01.12.2021 | Neurogastroenterology and Motility Disorders of the Gastrointestinal Tract (S Rao and A Sharma, Section Editors)

Foregut Dysmotility in the Lung Transplant Patient

verfasst von: Danny Wong, Walter W. Chan

Erschienen in: Current Gastroenterology Reports | Ausgabe 12/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To explore the role of upper gastrointestinal disease in the clinical course of lung transplant patients – including its pathophysiology, diagnostic testing, and treatment options.

Recent Findings

Gastroesophageal reflux disease (GERD) and foregut motility disorders are more prevalent among end-stage lung disease patients and are associated with poorer outcomes in lung transplant recipients. A proposed mechanism is the exposure of the lung allograft to aspirated contents, resulting in inflammation and rejection. Diagnostic tools to assess for these disorders include multichannel intraluminal impedance and pH (MII-pH) testing, high resolution esophageal manometry (HREM), and gastric emptying scintigraphy. The main treatment options are medical management with acid suppressants and/or prokinetic agents and anti-reflux surgery. In particular, data support the use of early anti-reflux surgery to improve outcomes.

Summary

Newer diagnostic tools such as MII-pH testing and HREM allow for the identification of both acid and non-acid reflux and esophageal motility disorders, respectively. Recent studies have demonstrated that early anti-reflux surgery within six months post-transplant better protects against allograft injury and pulmonary function decline when compared to late surgery. However, further prospective research is needed to evaluate the short and long-term outcomes of these diagnostic approaches and interventions.

Blumenstock DA, Lewis C. The first transplantation of the lung in a human revisited. Ann Thorac Surg. 1993;56(6):1423–5.PubMedCrossRef

Chambers DC, Yusen RD, Cherikh WS, Goldfarb SB, Kucheryavaya AY, Khusch K, Levvey BJ, Lund LH, Meiser B, Rossano JW, Stehlik J. The registry of the international society for heart and lung transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant. 2017;36(10):1047–59.PubMedCrossRef

Keck BM, Bennett LE, Fiol BS, Dally OP, Novick RJ, Hosenpud JD. Worldwide thoracic organ transplantation: a report from the UNOS/ISHLT International Registry for Thoracic Organ Transplantation. Clin Transpl. 1996;31–45.

Goh A. An analysis of liver transplant survival rates from the UNOS registry. Clin Transpl. 2008;19–34.

Yusen RD, Edwards LB, Kucheryavaya AY, et al. The Registry of the International Society for Heart and Lung Transplantation: thirtysecond official adult lung and heart-lung transplantation report—2015; focus theme: early graft failure. J Heart Lung Transplant. 2015;34:1264–77.PubMedCrossRef

Martinu T, Chen DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc. 2009;6:54–65.PubMedPubMedCentralCrossRef

Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant. 2002;21:271–81.PubMedCrossRef

Stewart S. Pathology of lung transplantation. Semin Diagn Pathol. 1992;9(3):210–9.PubMed

Yousem SA, et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant. 1996;15(1):1–15.PubMed

10.

Cooper JD, et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 1993;12(5):713–6.PubMed

11.

Traxler D, Schweiger T, Schwarz S, Schuster MM, Jaksch P, Lang G, Birner P, Klepetko W, Ankersmit HJ, Hoetzenecker K. The lymphatic phenotype of lung allografts in patients with bronchiolitis obliterans syndrome and restrictive allograft syndrome. Transplantation. 2017;101:310–5.PubMedCrossRef

12.

Sato M. Chronic lung allograft dysfunction. Gen Thorac Cardiovasc Surg. 2014;3:71–8.

13.

Verleden GM, Raghu G, Meyer KC, et al. A new classification system for chronic lung allograft dysfunction. J Heart Lung Transplant. 2014;33:127–33.PubMedCrossRef

14.

Sato M, Waddell TK, Wagnetz U, et al. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction. J Heart Lung Transplant. 2011;30:735–42.PubMedCrossRef

15.

Trulock EP, et al. The registry of the international society for heart and lung transplantation: twenty-first official adult lung and heart-lung transplant report–2004. J Heart Lung Transplant. 2004;23(7):804–15.PubMedCrossRef

16.

Valentine VG, et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant. 1996;15(4):371–83.PubMed

17.

Kroshus TJ, et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg. 1997;114(2):195–202.PubMedCrossRef

18.

Novick RJ, et al. Influence of graft ischemic time and donor age on survival after lung transplantation. J Heart Lung Transplant. 1999;18(5):425–31.PubMedCrossRef

19.

Hunt RH. Importance of pH control in the management of GERD. Arch Intern Med. 1999;159:649–57.PubMedCrossRef

20.

Basseri B, Conklin JL, Pimentel M, et al. Esophageal motor dysfunction and gastroesophageal reflux are prevalent in lung transplant candidates. Ann Thorac Surg. 2010;90:1630–6.PubMedCrossRef

21.

Sweet MP, Herbella FA, Leard L, et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg. 2006;244:491–7.PubMedPubMedCentral

22.

Gasper WJ, Sweet MP, Golden JA, et al. Lung transplantation in patients with connective tissue disorders and esophageal dysmotility. Dis Esophagus. 2008;21:650–5.PubMedCrossRef

23.

Seccombe J, Mirza F, Hachem R, Gyawali CP. Esophageal motor disease and reflux patterns in patients with advanced pulmonary disease undergoing lung transplant evaluation. Neurogastroenterol Motil. 2013;25(8):657–63.PubMedCrossRef

24.

Masuda T, Mittal SK, Kovács B, Smith MA, Walia R, Huang JL, Bremner RM. Foregut function before and after lung transplant. J Thorac Cardiovasc Surg. 2019;158(2):619–29.PubMedCrossRef

25.

Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124:1689–93.PubMedCrossRef

26.

Ciriza-de-los-Ríos C, Canga-Rodríguez-Valcárcel F, de-Pablo-Gafas A, Castel-de-Lucas I, Lora-Pablos D, Castellano-Tortajada G. Esophageal motor disorders are frequent during pre and post lung transplantation. Can they influence lung rejection? Rev Esp Enferm Dig. 2018;110(6):344–51.PubMed

27.

Posner S, Finn RT, Shimpi RA, Wood RK, Fisher D, Hartwig MG, Klapper J, Reynolds J, Niedzwiecki D, Parish A, Leiman DA. Esophageal contractility increases and gastroesophageal reflux does not worsen after lung transplantation. Dis Esophagus. 2019;32(10):1–8.PubMedCrossRef

28.

Raviv Y, D’Ovidio F, Pierre A, et al. Prevalence of gastroparesis before and after lung transplantation and its association with lung allograft outcomes. Clin Transplant. 2012;26:133–42.PubMedCrossRef

29.

Fisichella PM, Davis CS, Shankaran V, et al. The prevalence and extent of gastroesophageal reflux disease correlates to the type of lung transplantation. Surg Laparosc Endosc Percutan Tech. 2012;22:46–51.PubMedPubMedCentralCrossRef

30.

Kayawake H, Chen-Yoshikawa TF, Motoyama H, Hamaji M, Nakajima D, Aoyama A, Date H. Gastrointestinal complications after lung transplantation in Japanese patients. Surg Today. 2018;48(9):883–90.PubMedCrossRef

31.

Hadjiliadis D, Duane Davis R, Steele MP, Messier RH, Lau CL, Eubanks SS, Palmer SM. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant. 2003;17:363–8.PubMedCrossRef

32.

King BJ, Iyer H, Leidi AA, Carby MR. Gastroesophageal reflux in bronchiolitis obliterans syndrome: a new perspective. J Heart Lung Transplant. 2009;28:870–5.PubMedCrossRef

33.

Lo WK, Burakoff R, Goldberg HJ, Feldman N, Chan WW. Pre-lung transplant measures of reflux on impedance are superior to pH testing alone in predicting early allograft injury. World J Gastroenterol. 2015;21(30):9111–7.PubMedPubMedCentralCrossRef

34.

• Tangaroonsanti A, Lee AS, Crowell MD, et al. Impaired esophageal motility and clearance post-lung transplant: risk for chronic allograft failure. Clin Transl Gastroenterol. 2017;8(6):e102. (.)PubMedPubMedCentralCrossRef

35.

Lo WK, Goldberg HJ, Chan WW. Concurrent non-acid reflux is associated with chronic rejection in lung transplant patients with acid reflux on pre-transplant testing. Gastroenterology. 2018;154(6):S470–1.CrossRef

36.

Jamie Dy F, et al. Impact of gastroesophageal reflux and delayed gastric emptying on pediatric lung transplant outcomes. J Heart Lung Transplant. 2017;36(8):854–61.PubMedCrossRef

37.

Stovold R, Forrest IA, Corris PA, Murphy DM, Smith JA, Decalmer S, Johnson GE, Dark JH, Pearson JP, Ward C. Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection. Am J Respir Crit Care Med. 2007;175:1298–303.PubMedCrossRef

38.

Meltzer AJ, Weiss MJ, Veillette GR, Sahara H, Ng CY, Cochrane ME, Houser SL, Sachs DH, Rosengard BR, Madsen JC, Wain JC, Allan JS. Repetitive gastric aspiration leads to augmented indirect allorecognition after lung transplantation in miniature swine. Transplantation. 2008;86:1824–9.PubMedPubMedCentralCrossRef

39.

D’Ovidio F, Mura M, Tsang M, Waddell TK, Hutcheon MA, Singer LG, Hadjiliadis D, Chaparro C, Gutierrez C, Pierre A, Darling G, Liu M, Keshavjee S. Bile acid aspiration and the development of bronchiolitis obliterans after lung transplantation. J Thorac Cardiovasc Surg. 2005;129:1144–52.PubMedCrossRef

40.

Li B, Hartwig MG, Appel JZ, Bush EL, Balsara KR, Holzknecht ZE, Collins BH, Howell DN, Parker W, Lin SS, Davis RD. Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants. Am J Transplant. 2008;8:1614–21.PubMedPubMedCentralCrossRef

41.

Blondeau K, Mertens V, Vanaudenaerde BA, Verleden GM, Van Raemdonck DE, Sifrim D, Dupont LJ. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection. Eur Respir J. 2008;31:707–13.PubMedCrossRef

42.

Oelberg DG, Downey SA, Flynn MM. Bile salt-induced intracellular Ca++ accumulation in type II pneumocytes. Lung. 1990;168:297–308.PubMedCrossRef

43.

Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg. 1997;114:195–202.PubMedCrossRef

44.

Egan JJ. Obliterative bronchiolitis after lung transplantation: a repetitive multiple injury airway disease. Am J Respir Crit Care Med. 2004;170:931–2.PubMedCrossRef

45.

Ward C, Walters EH, Zheng L, Whitford H, Williams TJ, Snell GI. Increased soluble CD14 in bronchoalveolar lavage fluid of stable lung transplant recipients. Eur Respir J. 2002;19:472–8.PubMedCrossRef

46.

Posner S, Zheng J, Wood RK, Shimpi RA, Hartwig MG, Chow SC, Leiman DA. Gastroesophageal reflux symptoms are not sufficient to guide esophageal function testing in lung transplant candidates. Dis Esophagus. 2018;31(5).

47.

Lo WK, Goldberg HJ, Burakoff R, Feldman N, Chan WW. Low nocturnal baseline impedance is prevalent and a promising marker for reflux during pre-lung transplant evaluation. Gastroenterology. 2017;152(5):S658–9.CrossRef

48.

Masuda T, Mittal SK, Kovacs B, Smith M, Walia R, Huang J, Bremner RM. Thoracoabdominal pressure gradient and gastroesophageal reflux: insights from lung transplant candidates. Dis Esophagus. 2018;31(10).

49.

• Lo WK, Goldberg HJ, Boukedes S, et al. Proton pump inhibitors independently protect against early allograft injury or chronic rejection after lung transplantation. Dig Dis Sci. 2018;63:403–10. (This study demonstrated that acid suppression among transplant patients – excluding those who had undergone pre-transplant anti-reflux surgery – independently predicted against rejection on multivariate analysis. In particular, PPI but not H2RA exposure independently protected against early and chronic allograft injury after lung transplantation.)PubMedCrossRef

50.

Peeters TL. Erythromycin and other macrolides as prokinetic agents. Gastroenterology. 1993;105(6):1886–99.PubMedCrossRef

51.

Edelbroek MA, et al. Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects. J Nucl Med. 1993;34(4):582–8.PubMed

52.

Mertens V, Blondeau K, Oudenhove LV, et al. Bile acids aspiration reduces survival in lung transplant recipients with BOS despite azithromycin. Am J Transplant. 2011;11:329–35.PubMedCrossRef

53.

Vos R, Vanaudenaerde BM, Verleden SE, et al. Antiinflammatory and immunomodulatory properties of azithromycin involved in treatment and prevention of chronic lung allograft rejection. Transplantation. 2012;94:101–9.PubMedCrossRef

54.

Lidor AO, Ensor CR, Sheer AJ, Orens JB, Clarke JO, McDyer JF. Domperidone for delayed gastric emptying in lung transplant recipients with and without gastroesophageal reflux. Prog Transplant. 2014;24(1):27–32.PubMedCrossRef

55.

Cantu E. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease. Ann Thorac Surg. 2004;78(4):1142–51.PubMedCrossRef

56.

Abbassi-Ghadi N, Kumar S, Cheung B, McDermott A, Knaggs A, Zacharakis E, Moorthy K, Carby M, Hanna GB. Anti-reflux surgery for lung transplant recipients in the presence of impedance-detected duodenogastroesophageal reflux and bronchiolitis obliterans syndrome: a study of efficacy and safety. J Heart Lung Transplant. 2013;32(6):588–95.PubMedCrossRef

57.

Fisichella PM, et al. Pulmonary immune changes early after laparoscopic antireflux surgery in lung transplant patients with gastroesophageal reflux disease. J Surg Res. 2012;177(2):e65-73.PubMedPubMedCentralCrossRef

58.

• Biswas Roy S, et al. Early fundoplication is associated with slower decline in lung function after lung transplantation in patients with gastroesophageal reflux disease. J Thorac Cardiovasc Surg. 2018;155(6):2762–71. (This study showed that lung transplant patients who underwent early fundoplication (<6 months after transplantation) had higher FEV1 than those with late fundoplication. In particular, a linear mixed model demonstrated a 5.7% lower predicted FEV1 over time in the late fundoplication cohort.)PubMedCrossRef

59.

• Lo WK, Goldberg HJ, Wee J, Fisichella PM, Chan WW. Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation. J Gastrointest Surg. 2016;20(1):111–8. (This study demonstrated that late post-transplant anti-reflux surgery (≥6 months post-transplant) was associated with higher rates of allograft injury compared to pre-transplant and early post-transplant surgery (<6 months post-transplant). In particular, no difference in outcome was noted between pre-transplant and early post-transplant anti-reflux surgery. These findings suggest that the optimal time for anti-reflux surgery among lung transplant patients with GERD is within six months post-transplant.)PubMedCrossRef

60.

Amaris M, Machuca T, Pipkin M, Nandavaram S, Daouk S, Chandrashekaran S, Emtiazjoo A, Eagan C, Alnuaimat H, Pelaez A. Improvement of esophageal dysmotility with transelectrical stimulation (TES) in lung transplant patients. J Heart Lung Transplant. 2018;37(4):S242.CrossRef

61.

Weinkauf JG, et al. Transcutaneous electrical nerve stimulation for severe gastroparesis after lung transplantation. J Heart Lung Transplant. 2005;24(9):1444.PubMedCrossRef

62.

Filichia LA, Baz MA, Cendan JC. Simultaneous fundoplication and gastric stimulation in a lung transplant recipient with gastroparesis and reflux. JSLS. 2008;12(3):303–5.PubMedPubMedCentral

63.

Filichia LA, Cendan JC. Small case series of gastric stimulation for the management of transplant-induced gastroparesis. J Surg Res Vol. 2008;148(1):90–3.CrossRef

64.

Hooft N, Smith M, Huang J, Bremner R, Walia R. Gastroparesis is common after lung transplantation and may be ameliorated by botulinum toxin-A injection of the pylorus. J Heart Lung Transplant. 2014;33(12):1314–6.PubMedCrossRef

65.

Olufemi AA, Faul LJ, Vierra M, et al. The surgical management of severe gastroparesis in heart/lung transplant recipients. Chest. 2000;111:907–10.

Titel: Foregut Dysmotility in the Lung Transplant Patient
verfasst von: Danny Wong
Walter W. Chan
Publikationsdatum: 01.12.2021
Verlag: Springer US
Erschienen in: Current Gastroenterology Reports / Ausgabe 12/2021
Print ISSN: 1522-8037
Elektronische ISSN: 1534-312X
DOI: https://doi.org/10.1007/s11894-021-00824-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Foregut Dysmotility in the Lung Transplant Patient

Abstract

Purpose of Review

Recent Findings

Summary

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2021

Dietary Approaches for Management of Non-Alcoholic Fatty Liver Disease: A Clinician’s Guide

When Pandemics Collide: the Interplay of Obesity and COVID-19

Beyond the Eckardt Score: Patient-Reported Outcomes Measures in Esophageal Disorders

The Management of the Hospitalized Ulcerative Colitis Patient, the Medical—Surgical Conundrum

Portal Vein Thrombosis In Cirrhosis: Interventional Treatment Options

Newborn Screening for Biliary Atresia: a Review of Current Methods

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Viel Bewegung in der Parkinsonforschung

Adjuvante Immuntherapie verlängert Leben bei RCC

Update Innere Medizin